BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

195 related articles for article (PubMed ID: 26723972)

  • 1. Periostin activates pathways involved in epithelial-mesenchymal transition in adamantinomatous craniopharyngioma.
    Chen M; Zheng SH; Liu Y; Shi J; Qi ST
    J Neurol Sci; 2016 Jan; 360():49-54. PubMed ID: 26723972
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Interleukin‑6 induces an epithelial‑mesenchymal transition phenotype in human adamantinomatous craniopharyngioma cells and promotes tumor cell migration.
    Zhou J; Zhang C; Pan J; Chen L; Qi ST
    Mol Med Rep; 2017 Jun; 15(6):4123-4131. PubMed ID: 28487953
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Drug priming enhances radiosensitivity of adamantinomatous craniopharyngioma via downregulation of survivin.
    Stache C; Bils C; Fahlbusch R; Flitsch J; Buchfelder M; Stefanits H; Czech T; Gaipl U; Frey B; Buslei R; Hölsken A
    Neurosurg Focus; 2016 Dec; 41(6):E14. PubMed ID: 27903123
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Stromal POSTN induced by TGF-β1 facilitates the migration and invasion of ovarian cancer.
    Yue H; Li W; Chen R; Wang J; Lu X; Li J
    Gynecol Oncol; 2021 Feb; 160(2):530-538. PubMed ID: 33317907
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Periostin Plays a Key Role in Radioresistance of Head and Neck Cancer Cells
    Park JJ; Hah YS; Ryu S; Cheon SY; Cho HY; Kim JP; Won SJ; Lee JS; Hwa JS; Seo JH; Chang HW; Kim SY
    Anticancer Res; 2020 May; 40(5):2627-2635. PubMed ID: 32366407
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Periostin regulated by let-7/miR-98 family mediates the apoptosis and epithelial-mesenchymal transition of colon cancer].
    Fu Q; Cheng J; Zhang JD; Zhang YL; Chen XB; Xie JG; Luo SX
    Zhonghua Zhong Liu Za Zhi; 2019 Aug; 41(8):573-579. PubMed ID: 31434447
    [No Abstract]   [Full Text] [Related]  

  • 7. Differential Expression of Stem Cell Markers in Human Adamantinomatous Craniopharyngioma and Pituitary Adenoma.
    Chang CV; Araujo RV; Cirqueira CS; Cani CM; Matushita H; Cescato VA; Fragoso MC; Bronstein MD; Zerbini MC; Mendonca BB; Carvalho LR
    Neuroendocrinology; 2017; 104(2):183-193. PubMed ID: 27161333
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Multiplexed immunofluorescence reveals potential PD-1/PD-L1 pathway vulnerabilities in craniopharyngioma.
    Coy S; Rashid R; Lin JR; Du Z; Donson AM; Hankinson TC; Foreman NK; Manley PE; Kieran MW; Reardon DA; Sorger PK; Santagata S
    Neuro Oncol; 2018 Jul; 20(8):1101-1112. PubMed ID: 29509940
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Periostin concentrations in childhood-onset craniopharyngioma patients.
    Heinks K; De Schutter-Nüsse C; Boekhoff S; Bogusz A; Zhu J; Peng J; Müller HL
    J Endocrinol Invest; 2019 Jul; 42(7):815-824. PubMed ID: 30474798
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical and prognostic role of annexin A2 in adamantinomatous craniopharyngioma.
    Wang Y; Deng J; Guo G; Tong A; Peng X; Chen H; Xu J; Liu Y; You C; Zhou L
    J Neurooncol; 2017 Jan; 131(1):21-29. PubMed ID: 27640198
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Periostin gene expression in neu-positive breast cancer cells is regulated by a FGFR signaling cross talk with TGFβ/PI3K/AKT pathways.
    Labrèche C; Cook DP; Abou-Hamad J; Pascoal J; Pryce BR; Al-Zahrani KN; Sabourin LA
    Breast Cancer Res; 2021 Nov; 23(1):107. PubMed ID: 34809697
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Periostin Facilitates the Epithelial-Mesenchymal Transition of Endometrial Epithelial Cells through ILK-Akt Signaling Pathway.
    Zheng QM; Lu JJ; Zhao J; Wei X; Wang L; Liu PS
    Biomed Res Int; 2016; 2016():9842619. PubMed ID: 27034956
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Does the calcification of adamantinomatous craniopharyngioma resemble the calcium deposition of osteogenesis/odontogenesis?
    Song-Tao Q; Xiao-Rong Y; Jun P; Yong-Jian D; Jin L; Guang-Long H; Yun-Tao L; Jian R; Xiang-Zhao L; Jia-Ming X
    Histopathology; 2014 Feb; 64(3):336-47. PubMed ID: 24387671
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Epithelial-mesenchymal transition and clinicopathological correlation in craniopharyngioma.
    Qi ST; Zhou J; Pan J; Zhang C; Silky C; Yan XR
    Histopathology; 2012 Oct; 61(4):711-25. PubMed ID: 23551434
    [TBL] [Abstract][Full Text] [Related]  

  • 15. POSTN promotes proliferation and epithelial-mesenchymal transition in renal cell carcinoma through ILK/AKT/mTOR pathway.
    Jia YY; Yu Y; Li HJ
    J Cancer; 2021; 12(14):4183-4195. PubMed ID: 34093819
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Opposite regulation of epithelial-to-mesenchymal transition and cell invasiveness by periostin between prostate and bladder cancer cells.
    Kim CJ; Sakamoto K; Tambe Y; Inoue H
    Int J Oncol; 2011 Jun; 38(6):1759-66. PubMed ID: 21468544
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Adamantinomatous craniopharyngioma: moving toward targeted therapies.
    Hengartner AC; Prince E; Vijmasi T; Hankinson TC
    Neurosurg Focus; 2020 Jan; 48(1):E7. PubMed ID: 31896087
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Tumour compartment transcriptomics demonstrates the activation of inflammatory and odontogenic programmes in human adamantinomatous craniopharyngioma and identifies the MAPK/ERK pathway as a novel therapeutic target.
    Apps JR; Carreno G; Gonzalez-Meljem JM; Haston S; Guiho R; Cooper JE; Manshaei S; Jani N; Hölsken A; Pettorini B; Beynon RJ; Simpson DM; Fraser HC; Hong Y; Hallang S; Stone TJ; Virasami A; Donson AM; Jones D; Aquilina K; Spoudeas H; Joshi AR; Grundy R; Storer LCD; Korbonits M; Hilton DA; Tossell K; Thavaraj S; Ungless MA; Gil J; Buslei R; Hankinson T; Hargrave D; Goding C; Andoniadou CL; Brogan P; Jacques TS; Williams HJ; Martinez-Barbera JP
    Acta Neuropathol; 2018 May; 135(5):757-777. PubMed ID: 29541918
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Possible linkage between specific histological structures and aberrant reactivation of the Wnt pathway in adamantinomatous craniopharyngioma.
    Kato K; Nakatani Y; Kanno H; Inayama Y; Ijiri R; Nagahara N; Miyake T; Tanaka M; Ito Y; Aida N; Tachibana K; Sekido K; Tanaka Y
    J Pathol; 2004 Jul; 203(3):814-21. PubMed ID: 15221941
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Expression of epithelial cell adhesion molecule and pituitary tumor transforming gene in adamantinomatous craniopharyngioma and its correlation with recurrence of the tumor.
    Tena-Suck ML; Ortiz-Plata A; Galán F; Sánchez A
    Ann Diagn Pathol; 2009 Apr; 13(2):82-8. PubMed ID: 19302955
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.